Mouse regenerating myofibers detected as false-positive donor myofibers with anti-human spectrin

Human Gene Therapy

Volumn 25, Issue 1, 2014, Pages 73-81

  Rozkalne, Anete ^a   Adkin, Carl ^b   Meng, Jinhong ^b   Lapan, Ariya ^a   Morgan, Jennifer E ^b   Gussoni, Emanuela ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; SPECTRIN ANTIBODY; UNCLASSIFIED DRUG; UTROPHIN;

ANIMAL EXPERIMENT; ARTICLE; CELL REGENERATION; DONOR; FALSE POSITIVE RESULT; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; STEM CELL TRANSPLANTATION; TISSUE SECTION;

ANIMALS; ANTIGENS, CD146; DISEASE MODELS, ANIMAL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED MDX; MUSCLE FIBERS, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS, SKELETAL; REGENERATION; SPECTRIN; TISSUE DONORS;

EID: 84892860461     PISSN: 10430342     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2013.126     Document Type: Article

References (47)

1. Beauchamp, J. R., Morgan, J. E., Pagel, C. N., and Partridge, T. A. (1999). Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144, 1113-1122.
2. Boldrin, L., Neal, A., Zammit, P. S., et al. (2012). Donor satellite cell engraftment is significantly augmented when the host niche is preserved and endogenous satellite cells are incapacitated. Stem Cells 30, 1971-1984.
3. Borrione, A. C., Zanellato, A. M., Scannapieco, G., et al. (1989). Myosin heavy-chain isoforms in adult and developing rabbit vascular smooth muscle. Eur. J. Biochem. 183, 413-417.
4. Brimah, K., Ehrhardt, J., Mouly, V., et al. (2004). Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum. Gene Ther. 15, 1109-1124.
5. Byers, T. J., Lidov, H. G., and Kunkel, L. M. (1993). An alternative dystrophin transcript specific to the peripheral nerve. Nat. Genet. 4, 77-80.
6. Cooper, R. N., Irintchev, A., Di Santo, J. P., et al. (2001). A new immunodeficient mouse model for human myoblast transplantation. Hum. Gene Ther. 12, 823-831.
7. Cooper, R. N., Thiesson, D., Furling, D., et al. (2003). Extended amplification in vitro and replicative senescence: Key factors implicated in the success of human myoblast transplantation. Hum. Gene Ther. 14, 1169-1179.
8. Crisan, M., Yap, S., Casteilla, L., et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301-313.
9. Darabi, R., Arpke, R. W., Irion, S., et al. (2012). Human ES-and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 10, 610-619.
10. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat. Cell Biol. 9, 255-267.
11. Ehrhardt, J., Brimah, K., Adkin, C., et al. (2007). Human muscle precursor cells give rise to functional satellite cells in vivo. Neuromuscul. Disord. 17, 631-638.
12. Flanagan, S. P. (1966). ''Nude,'' a new hairless gene with pleiotropic effects in the mouse. Genet. Res. 8, 295-309.
13. Goudenege, S., Lebel, C., Huot, N. B., et al. (2012). Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation. Mol. Ther. 20, 2153-2167.
14. Gramolini, A. O., Karpati, G., and Jasmin, B. J. (1999). Discordant expression of utrophin and its transcript in human and mouse skeletal muscles. J. Neuropathol. Exp. Neurol. 58, 235-244.
15. Gross, J. G., and Morgan, J. E. (1999). Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve 22, 174-185.
16. Gussoni, E., Pavlath, G. K., Lanctot, A. M., et al. (1992). Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 356, 435-438.
17. Gussoni, E., Blau, H. M., and Kunkel, L. M. (1997). The fate of individual myoblasts after transplantation into muscles of DMD patients. Nat. Med. 3, 970-977.
18. Hoffman, E. P., Brown, R. H., Jr., and Kunkel, L. M. (1987). Dystrophin: The protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
19. Hoffman, E. P., Morgan, J. E., Watkins, S. C., and Partridge, T. A. (1990). Somatic reversion/suppression of the mouse mdx phenotype in vivo. J. Neurol. Sci. 99, 9-25.
20. Huard, J., Bouchard, J. P., Roy, R., et al. (1992). Human myoblast transplantation: Preliminary results of 4 cases. Muscle Nerve 15, 550-560.
21. Huard, J., Roy, R., Guérette, B., et al. (1994). Human myoblast transplantation in immunodeficient and immunosuppressed mice: Evidence of rejection. Muscle Nerve 17, 224-234.
22. Karpati, G. (1990). The principles and practice of myoblast transfer. Adv. Exp. Med. Biol. 280, 69-74.
23. Karpati, G., Ajdukovic, D., Arnold, D., et al. (1993). Myoblast transfer in Duchenne muscular dystrophy. Ann. Neurol. 34, 8-17.
24. Lapan, A. D., and Gussoni, E. (2012). Isolation and characterization of human fetal myoblasts. Methods Mol. Biol. 798, 3-19.
25. Lapan, A. D., Rozkalne, A., and Gussoni, E. (2012). Human fetal skeletal muscle contains a myogenic side population that expresses the melanoma cell-adhesion molecule. Hum. Mol. Genet. 21, 3668-3680.
26. Lidov, H. G. W., Byers, T. J., Watkins, S. C., and Kunkel, L. M. (1990). Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 348, 725-728.
27. Lu, Q. L., Morris, G. E., Wilton, S. D., et al. (2000). Massive idiosyncratic exon skipping corrects the nonsense mutation in dystrophic mouse muscle and produces functional revertant fibers by clonal expansion. J. Cell Biol. 148, 985-996.
28. Mendell, J. R., Kissel, J. T., Amato, A. A., et al. (1995). Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333, 832-838.
29. Meng, J., Adkin, C. F., Arechavala-Gomeza, V., et al. (2010). The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul. Disord. 20, 6-15.
30. Meng, J., Adkin, C. F., Xu, S. W., et al. (2011). Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice. PLoS One 6, e17454.
31. Monaco, A. P., Neve, R. L., Colletti-Feener, C., et al. (1986). Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646-650.
32. Morandi, L., Bernasconi, P., Gebbia, M., et al. (1995). Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Neuromuscul. Disord. 5, 291-295.
33. Negroni, E., Riederer, I., Chaouch, S., et al. (2009). In vivo myogenic potential of human CD133+ muscle-derived stem cells: A quantitative study. Mol. Ther. 17, 1771-1778.
34. Neumeyer, A. M., Cros, D., McKenna-Yasek, D., et al. (1998). Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neurology 51, 589-592.
35. Pantelouris, E. M. (1968). Absence of thymus in a mouse mutant. Nature 217, 370-371.
36. Partridge, T. A., Morgan, J. E., Coulton, G. R., et al. (1989). Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts. Nature 337, 176-179.
37. Pye, D., Watt, D. J., Walker, C., et al. (2004). Identification of the RAG-1 as a suitable mouse model for mitochondrial DNA disease. Neuromuscul. Disord. 14, 329-336.
38. Rivier, F., Alkan, O., Flint, A. F., et al. (2004). Role of bone marrow cell trafficking in replenishing skeletal muscle SP and MP cell populations. J. Cell Sci. 117, 1979-1988.
39. Rybakova, I. N., and Ervasti, J. M. (2005). Identification of spectrin-like repeats required for high affinity utrophin-actin interaction. J. Biol. Chem. 280, 23018-23023.
40. Shultz, L. D., Lang, P. A., Christianson, S. W., et al. (2000). NOD/ LtSz-Rag1null mice: An immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells. J. Immunol. 164, 2496-2507.
41. Shultz, L. D., Lyons, B. L., Burzenski, L. M., et al. (2005). Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rcnull mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477-6489.
42. Shultz, L. D., Ishikawa, F., and Greiner, D. L. (2007). Humanized mice in translational biomedical research. Nat. Rev. Immunol. 7, 118-130.
43. Tedesco, F. S., Gerli, M. F., Perani, L., et al. (2012). Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci. Transl. Med. 4, 140ra89.
44. Tennyson, C. N., Klamut, H. J., and Worton, R. G. (1995). The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9, 184-190.
45. Torrente, Y., Belicchi, M., Sampaolesi, M., et al. (2004). Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J. Clin. Invest. 114, 182-195.
46. Yokota, T., Lu, Q. L., Morgan, J. E., et al. (2006). Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J. Cell Sci. 119, 2679-2687.
47. Zheng, B., Cao, B., Crisan, M., et al. (2007). Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat. Biotechnol. 25, 1025-1034.